Table 2. Recommended Adult Immunization Schedule by Medical Condition and Other Indications, United States, 2020
¶ = Recommended vaccination for adults who meet age requirement, lack documentation of vaccination, or lack evidence of past infection
§ = Recommended vaccination for adults with an additional risk factor or another indication
| = Precaution—vaccination might be indicated if benefit of protection outweighs risk of adverse reaction
^ = Delay vaccination until after pregnancy if vaccine is indicated
± = Not recommended/ contraindicated —vaccine should not be administered
• = No recommendation/ Not applicable
Vaccine | Pregnancy | Immuno-compromised (excluding HIV infection) |
HIV infection CD4 count |
Asplenia, complement deficiencies | End-stage renal disease; or on hemodialysis | Heart or lung disease, alcoholism1 | Chronic liver disease |
Diabetes | Health care personnel2 | Men who have sex with men | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
<200 | ≥200 | |||||||||||
IIV or RIV | 1 dose annually¶ | |||||||||||
LAIV |
NOT RECOMMENDED± | PRECAUTION| | 1 dose annually¶ |
|||||||||
Tdap or Td | 1 dose Tdap each pregnancy¶ | 1 dose Tdap, then Td or Tdap booster every 10 yrs¶ | ||||||||||
MMR | NOT RECOMMENDED± | 1 or 2 doses depending on indication¶ | ||||||||||
VAR | NOT RECOMMENDED± | 2 doses¶ | ||||||||||
RZV (preferred) | DELAY^ | • | • | • | 2 doses at age ≥50 yrs¶ | |||||||
ZVL |
NOT RECOMMENDED± | • | 1 dose at age ≥60 yrs¶ |
|||||||||
HPV | DELAY^ | 3 doses through age 26 yrs¶ | 2 or 3 doses through age 26 yrs¶ | |||||||||
PCV13 | • | 1¶ | dose§ | |||||||||
PPSV23 | § | 1, 2,or 3 doses depending on age¶ | and indication§ | |||||||||
HepA | § | ¶ | § | 2 or 3§ | doses¶ | depending on vaccine§ | ¶ | |||||
HepB | § | ¶ | § | ¶ | 2 or 3§ | doses depending on vaccine¶ | ||||||
MenACWY | 1 or 2 doses§ | depending on indication,¶ | see notes for booster recommendations§ | |||||||||
MenB | PRECAUTION| | 2 or 3 doses§ | depending on¶ | vaccine and indication, see notes for booster recommendations§ | ||||||||
Hib | • | 3 doses HSCT3 recipients only¶ | § | 1¶ | dose§ |